Physician profile
Jillian Risa Goro
NPI 1710640925
$704.19
in general payments reported to CMS, 2019-2025
12 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $44.03 · 2024: $311 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $123.36 | 2024-2025 | |
| Novo Nordisk INC | $105.46 | 2024-2025 | Ozempic |
| Lilly USA, LLC | $92.05 | 2024-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $85.76 | 2024-2025 | Airsupra, Farxiga |
| Amgen INC. | $71.03 | 2024-2025 | Otezla, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $57.93 | 2025 | Lagevrio, Gardasil 9, Capvaxive |
| Bolton Medical INC | $44.03 | 2022 | |
| Glaxosmithkline, LLC. | $39.50 | 2024-2025 | Arexvy, Shingrix, Bexsero |
| Pfizer INC. | $34.41 | 2024-2025 | |
| Viiv Healthcare Company | $20.10 | 2024 | Apretude |
| Exact Sciences Corporation | $16.10 | 2025 | The Cologuard Plus Collection Kit |
| Dexcom, INC. | $14.46 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Goro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.